THE VILLAGES, Fla., Oct. 25, 2024 /PRNewswire/ -- K2 Medical Research is proud to announce a significant milestone in the fight against Alzheimer's disease: the successful randomization of the first patient in the world for the J&J ReTain study. This groundbreaking clinical trial aims to...
K2 Medical Research, The Villages Achieves Landmark Milestone in Alzheimer's Research
Seaking AlphaSeeking Alpha / Seaking Alpha 4 hours ago 1 Views
Comments